EUVIMEDDescobrir EUVIMED
Open access · CC BY-NC 4.0

Impact of Immunosuppressive Drug Concentrations on Microvascular Inflammation, Negative Donor‐Specific Antibodies, and C4d‐Negative Status in Kidney Transplant Recipients

Yoichi Kakuta iD, Yoko Maegawa-Higa, Soichi Matsumura, Shota Fukae, Ryo Tanaka iD, Hiroaki Yonishi, Shigeaki Nakazawa, Tomoko Namba-Hamano, Yoshitaka Isaka, Norio Nonomura

Clinical Transplantation · 2025

DOI: 10.1111/ctr.70112 ↗

At a glance

Journal article in Clinical Transplantation, 2025. Written by Yoichi Kakuta and 9 co-authors. Institution: Department of Urology, Osaka Graduate School of Medicine, Suita, Osaka, Japan. Major MEDLINE topics: Kidney Transplantation, Immunosuppressive Agents, Graft Rejection, Isoantibodies. Cited 3 times so far (Crossref); 21 references. The full text is freely available (open access, CC BY-NC 4.0).

ResumoSubjectsDados bibliográficosCiteRelated studies

Abstract (original language)

Introduction

This study investigated the impact of immunosuppressive drug concentrations on microvascular inflammation (MVI) in kidney transplant recipients with negative donor‐specific antibodies (DSA) against human leukocyte antigen (HLA) and negative C4d deposition in peritubular capillaries.

Methods

We analyzed data from 268 living kidney transplant recipients at the Department of Urology, University of Osaka, Japan. Patients received immunosuppressive therapy comprising extended‐release tacrolimus, mycophenolate mofetil (MMF), and/or everolimus, with or without steroids. Graft biopsies were routinely performed at 3, 12, 36 and 60 months post‐surgery.

Results

No significant differences were observed between the MVI+DSA‐C4d‐ and MVI‐DSAC4d groups regarding graft survival rates (95.5% vs. 96.6%, p = 0.772) or patient survival rates (95.7% vs. 95.9%, p = 0.735). Lower tacrolimus and everolimus concentrations were significantly associated with an increased risk of MVI+DSA‐C4d‐ (tacrolimus: OR, 0.169; 95% CI, 0.055–0.515; p = 0.002; everolimus: OR, 0.386; 95% CI, 0.171–0.874; p = 0.022). In contrast, MPA concentration was not significantly associated with MVI+DSA‐C4d‐ (OR, 0.994; 95% CI, 0.554–1.780; p = 0.984). Steroid discontinuation did not significantly impact the risk of MVI+DSA‐C4d‐ (OR, 1.980; 95% CI, 0.318–12.000; p = 0.470).

Conclusion

Lower trough levels of tacrolimus and everolimus correlated with a higher incidence of antibody‐independent MVI, supporting the need for tailored immunosuppressive regimens in kidney transplantation.

Subjects

MeSH terms (MEDLINE)

Kidney TransplantationImmunosuppressive AgentsGraft RejectionIsoantibodiesComplement C4bPeptide FragmentsInflammationKidney Failure, ChronicMicrovesselsHumansMaleFemaleMiddle AgedGraft SurvivalFollow-Up StudiesPrognosisGlomerular Filtration RateAdultRisk FactorsKidney Function TestsRetrospective StudiesHLA AntigensTacrolimusAgedMycophenolic AcidSurvival RateTissue Donors

Author keywords

C4ddonor‐specific antibodiesgraft rejectionimmunosuppressive drugskidney transplantationmicrovascular inflammationtransplant immunology

Substances

Immunosuppressive AgentsIsoantibodiesComplement C4bcomplement C4dPeptide FragmentsHLA AntigensTacrolimusMycophenolic Acid

Authors and institutions

  • Department of Urology, Osaka Graduate School of Medicine, Suita, Osaka, Japan.
  • Department of Nephrology, Osaka Graduate School of Medicine, Suita, Osaka, Japan.

ORCID profiles: Yoichi Kakuta, Ryo Tanaka

Cite

APA

Kakuta, Y., Maegawa-Higa, Y., Matsumura, S., Fukae, S., Tanaka, R., Yonishi, H., Nakazawa, S., Namba-Hamano, T., Isaka, Y., & Nonomura, N. (2025). Impact of Immunosuppressive Drug Concentrations on Microvascular Inflammation, Negative Donor‐Specific Antibodies, and C4d‐Negative Status in Kidney Transplant Recipients. Clinical Transplantation. https://doi.org/10.1111/ctr.70112

Vancouver

Kakuta Y, Maegawa-Higa Y, Matsumura S, Fukae S, Tanaka R, Yonishi H, et al. Impact of Immunosuppressive Drug Concentrations on Microvascular Inflammation, Negative Donor‐Specific Antibodies, and C4d‐Negative Status in Kidney Transplant Recipients. Clinical Transplantation. 2025. doi:10.1111/ctr.70112

BibTeX
@article{Kakuta2025,
  author = {Kakuta, Yoichi and Maegawa-Higa, Yoko and Matsumura, Soichi and Fukae, Shota and Tanaka, Ryo and Yonishi, Hiroaki and Nakazawa, Shigeaki and Namba-Hamano, Tomoko and Isaka, Yoshitaka and Nonomura, Norio},
  title = {Impact of Immunosuppressive Drug Concentrations on Microvascular Inflammation, Negative Donor‐Specific Antibodies, and C4d‐Negative Status in Kidney Transplant Recipients},
  journal = {Clinical Transplantation},
  year = {2025},
  doi = {10.1111/ctr.70112}
}
Start for free →